OptimizeRx Grows Patient Communication Platform with RMDY Acquisition

OptimizeRx Grows Patient Communication Platform with RMDY Acquisition

OptimizeRx (NYSE: OPRX), a digital patient communication company, ramped up its platform last week with the acquisition of RMDY Health for $16 million. RMDY offers a SaaS platform that provides a complete digital framework to help life science and healthcare stakeholders design and launch their own white-label collaborative digital care and patient support programs. The company’s web and mobile platform supports a wide range of digital therapeutic initiatives, with a focus on care and chronic disease management, among others. For 2019, the company has an estimated annual revenue of $3 million. The acquisition adds three new client segments to OptimizeRx’s existing patient... Read More »
OptimizeRx Adds CareSpeak Communications

OptimizeRx Adds CareSpeak Communications

OptimizeRx Corporation (NYSE: OPRX) is heavily invested in healthcare communications. Its primary business provides digital health messaging via electronic health records (EHRs), offering a direct channel for pharma companies to communicate with healthcare providers. That makes its recent $9 million acquisition of privately held CareSpeak Communications so logical. CareSpeak, based in Somerset, New Jersey, provides patient engagement, medical therapy adherence, and care coordination solutions to insurers, pharmaceutical companies, pharmacies, and specialty pharmacies. OptimizeRx’s cloud-based solution supports patient adherence to medications by providing real-time access to financial... Read More »